You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
The recent revelations of problems in gene therapy trials have clearly indicated that the current federal mechanisms for review, regulation, and oversight of human gene transfer studies require modification. This policy forum discusses the basic principles that form the foundation of clinical research, with the most important being patient protection, and makes recommendations for changes in oversight that will ensure that the highest standards are met.
